The efficiency of the HPV vaccination program in reducing the prevalence of cervical cancers.
Gene-Guided Immunotherapy Misses Mark in Recurrent/Metastatic Head and Neck Cancer
Gene-guided treatment selection for recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) failed to improve disease control versus random treatment selection in a small preliminary